1/40
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
Other N2 containing compounds
Porphyrins (heme)
Neurotransmitters
Hormones
Purines
Pyrmidines
Sources of input for the AA pool
Dietary proteins (100g/day)
Degredation of BPdy proteins (400g/day)
Amino Acid Synthesis de novo (NEAA)
Fates of output from the AA pool
Synthesis of proteins
Catabolism into CO2 + H2O + NH3
Synthesis of other N2 containing compounds (30 - 40g/day)
Nitrogen Balance
balance of (Nin - Nout) in a 24 hour period
determined by : protein intake (g) /6.25-(UUN + 4g)
UUN = urinary loss
Positive N2 balance
When intake > excretion
Occurs during tissue growth (pregnancy, childhood, recovery from illness)
Negative N2 balance
When intake < excretion
Associated with inadequate dietary protein, lack of essential AAs or physiologic stress
Steps of chemical communication
Signal production and release
Signal Reception
Signal transmission and amplification
Response
Catecholamines
Dopamine, Epinephrine, Norepinephrine
Location of Dopamine production
Presynaptic Neurons
Location of Dopamine storage
Vesicles
Location of Epinephrine and Norepinephrine production
Adrenal medulla
Tyrosine
Precursor of Catecholamines
Tyrosine Hydroxylase
Rate-limiting step of Catecholamine synthesis
Tetrahydrobioprotein - BH4
Coenzyme required for step 1 of Catecholamine synthesis, which makes L-DOPA
Synthesized from GTP
Pyridoxal Phosphate (PLP)
Coenzyme required for step 2 of Catecholamine synthesis, which makes dopamine
decarboxylation rxn
Ascorbate (Vit C) and Copper
Coenzymes required for step 3 of Catecholamine synthesis, which makes norepinephrine
Catecholamine Synthesis overview
L-Tyrosine → L-Dopa → Dopamine → Norepinephrine → Epinephrine
Parkinson Disease
Neurodegenrative movement disorder due to insufficient dopamine production due to loss of dopamine producing cells in the brain
Levodopa (L-DOPA)
most common treatment for parkinsons
Carbidopa
Treatment for parkinsons
inhibits the enzyme converting L-DOPA to dopamine in the peripheral nervous system. It cannot cross the blood–brain barrier, and when used in tandem with L-DOPA, it allows more peripheral L-DOPA to cross the BBB in order to reach a more therapeutic range in the CNS
MAO
degrades neurotransmitters in their first reuptake into vesicles of the presynaptic neuron via oxidative deanimation
degrades 50% of catecholamines
COMT
degrades neurotransmitters in their second reuptake into the effector cell
MAO inhibitors
used as antidepressants and treatment of some neurologic disorders: Result in increased levels of NTs in the
presynaptic neurons
Tryptophan
Precursor of Serotonin
PLP and BH4
coenzymes needed in Serotonin synthesis
Termination of Serotonin
Re-uptake into the neuron by SERT
MAO
Implications of serotonin
regulation of sleep, cognitive function, and mood
Activates reflexes in GI
Precursor for melatonin
SSRIs
result in higher levels of serotonin in the synaptic
space.
“Designer drugs”
work through serotonin-containing neurons
Histidine
Precursor of Histamine
PLP
only coenzyme required for Histamine synthesis
Implications of Histidine
regulation of food and water intake
autonomics
brain functions such as learning and memory
allergic and inflammatory mediator
does not cross the blood brain barrier
Arginine
Precursor of NO synthesis
Nitric Oxide Synthase (nNOS)
Enzyme of NO Synthesis in neurons (is Ca++ dependent)
iNOS
Enzyme of NO Synthesis in immune cells (is NOT Ca++ dependent, but IS inducible by cytokines)
eNOS
Enzyme of NO Synthesis in endothelial cells (is Ca++ dependent)
Phosphocreatinine
A high energy phosphate molecule that can reversibly transfer the
phospho group to ADP to produce ATP found in brain, skeletal, and muscle cells
Synthesis of creatine phosphate
Begins in the kidney,
then in liver
Phosphorylation step - in the respective tissue (brain, heart, skeletal muscle) by Creatine (phospho) kinase (CPK or CK) (reversible step)
Degradation and excretion of Creatine Phosphate
Spontaneous cyclization to creatinine
Rapidly cleared from the blood and excreted in the urine via the kidney
increased blood creatinine levels
indicator of kidney dysfunction
increased levels of creatinine
used as diagnostic measure of muscle loss